Detachol Clinical Evidence & Resources

Sales Materials & Resources

Clinical Evidence

Use the table below to browse our clinical evidence or sort by keyword. To access the data click the ‘View’ column.

wdt_ID Category Author Key Findings Purpose Setting Devuce/Dressing being removed in study View Data
1 Patient Safety
Fowler¹
Detachol® Adhesive Remover has been found to be safe and effective in an irritancy study, with patch-and-repeat open application testing revealing no propensity toward allergic or irritant contact dermatitis.
To determine the role Detachol® may play in local skin reactions
Laboratory setting/ volunteers
N/A
View
2 Patient Safety
Ryder and Duley² No significant difference in the reduction of normal skin flora was observed on skin prepped with CHG/IPA vs skin prepped with CHG/IPA followed by Mastisol or Detachol. Use of Mastisol or Detachol did not affect the antiseptic effectiveness CHG/IPA.
Evaluated compatibility of 2% clorhexidine gluconate/70% isopropyl alcohol (CHG/IPA) with Mastisol and Detachol to determine whether either product affected the antiseptic effectiveness of CHG/IPA.
Laboratory setting/ volunteers
N/A
View
3 Patient Safety
Deneau and Craig³
Cookeville Regional Medical Center
Observations of multiple patients who have received application of Detachol® Adhesive Remover before dressing removal have revealed a low incidence of allergic reaction, effective removal of adhesive residue, increased nursing efficiency associated with removal of tape and dressings, and decreased patient pain with adhesive product removal.
Evaluated effectiveness of products for enhancing CVC dressing securement and removal.
ICU
CVC Dressings
View
4 Patient Safety
DeVries et al.⁴
Methodist Hospitals
Over 8,000 peripheral intravenous sites were assessed. The authors reported dressing integrity was improved and no dressing-related skin injuries were reported based on continuous consultation with wound nurses.
Assessed peripheral IV (PIV) dressing adherence following implementation of care bundle including Mastisol and Detachol in a pilot study
Large community hospital
PIV and CVC Dressings
View
5 Patient Safety
McNichol et al.⁵
Research reports have demonstrated that the use of solvents to break the adhesive bond between the skin and an adhesive product is an effective method for preventing skin injury associated with adhesive removal.
To define best practices for prevention of medical adhesive-related skin injury (MARSI). A multidisciplinary group of subject matter experts outlined consensus statements on the assessment, prevention, and treatment of medical adhesive-related skin injury.
Consensus Panel
N/A
View
6 Cost Avoidance
Groom et al.⁶
Economic studies have reported that the cost to treat a skin tear from incidence to complete resolution (approximately 2 weeks) is $21.96 per week.
Pilot study comparing a regimen using a skin care product line containing active ingredients and nutrients with a commercially available alternative skin care regimen. Incidence of skin tear data was collected.
Elderly convalescent care hospital-based center
N/A
View
Category Author Key Findings Purpose Setting Devuce/Dressing being removed in study View Data

Need more assistance? We’re happy to connect you with your local representative, give us an email at information@eloquesthealthcare.com!

Detachol Video Library

References

1. Data on file: Irritancy testing results.
2. Ryder M, Duley C. Evaluation of compatibility of gum mastic liquid adhesive and liquid adhesive remover with an alcoholic chlorhexadine skin preparation. J Infus Nurs. 2016;40(4):245-252.
3. Deneau J, Craig A. Nursing Survey Reveals Novel Strategy in Assisting Adherence to Best Practices of CVC Dressing Management. Poster presented at: Institute for Healthcare Improvement National Forum, December 8-11, 2013.
4. DeVries M, Sabenoff J, Wickert M. Addressing the Dressing Improving Dressing Disruption in Vascular Access. Poster presented at: 43rd Annual Canadian Vascular Access Conference, April 25-27, 2018.
5. McNichol L, Lund C, Rosen T, Gray M. Medical adhesives and patient safety: state of the science: consensus statements for the assessment, prevention, and treatment of adhesive-related skin injuries. J Wound Ostomy Continence Nurs. 2013 Jul-Aug; 40(4): 365-80; quiz E1-2. doi: 10.1097/WON.0b013e3182995516.
6. Groom M, Shannon RJ, Chakravarthy D, Fleck CA. An evaluation of costs and effects of a nutrient-based skin care program as a component of prevention of skin tears in an extended convalescent center. J Wound Ostomy Continence Nurs. 2010 Jan-Feb; 37(1): 46-51. doi: 10.1097/WON.0b013e3181c68c89. Erratum in: J Wound Ostomy Continence Nurs. 2010 Mar-Apr; 37(2): 128.